Literature DB >> 7961157

WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.

T Iwamoto1, A Fujie, K Nitta, S Hashimoto, M Okuhara, M Kohsaka.   

Abstract

WF11899A, B and C, novel water-soluble lipopeptides related to the echinocandins, possess potent anti-Candida activities. The IC50s of the compounds against four clinical isolates of Candida albicans ranged from 0.004 to 0.03 microgram/ml by microbroth dilution assay. These compounds mildly suppressed the growth of Aspergillus fumigatus and A. niger. WF11899A, B and C showed a potent in vivo anti-Candida activity. Particularly, WF11899A was superior to cilofungin, and equal to fluconazole. 1,3-beta-glucan synthase was inhibited by these compounds at the IC50s of 0.7, 0.7 and 1.8 micrograms/ml for WF11899A, B and C, respectively. However, they hemolysed mouse red blood cells in vitro at the concentration of 62 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961157     DOI: 10.7164/antibiotics.47.1092

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

Review 1.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.

Authors:  M Ito; R Nozu; T Kuramochi; N Eguchi; S Suzuki; K Hioki; T Itoh; F Ikeda
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Therapeutic effects of water-soluble echinocandin compounds on Pneumocystis pneumonia in mice.

Authors:  T Furuta; H Muramatsu; A Fujie; S Fujihira; N R Abudullah; S Kojima
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

5.  Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection.

Authors:  Ikuko Nakamura; Ryuichi Kanasaki; Koji Yoshikawa; Shigetada Furukawa; Akihiko Fujie; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2016-08-31       Impact factor: 2.649

Review 6.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

7.  Agrobacterium-tumefaciens-mediated transformation of antifungal-lipopeptide-producing fungus Coleophoma empetri F-11899.

Authors:  Masato Yamada; Kazunobu Yawata; Yohsuke Orino; Satoshi Ueda; Yasuhiro Isogai; Goro Taguchi; Makoto Shimosaka; Seiji Hashimoto
Journal:  Curr Genet       Date:  2009-10-30       Impact factor: 3.886

8.  Functional redundancy in Echinocandin B in-cluster transcription factor ecdB of Emericella rugulosa NRRL 11440.

Authors:  Arvind Kumar; Varun Jaiswal; Vinay Kumar; Amitava Dey; Antresh Kumar
Journal:  Biotechnol Rep (Amst)       Date:  2018-06-09

9.  IMA Genome-F 9: Draft genome sequence of Annulohypoxylon stygium, Aspergillus mulundensis, Berkeleyomyces basicola (syn. Thielaviopsis basicola), Ceratocystis smalleyi, two Cercospora beticola strains, Coleophoma cylindrospora, Fusarium fracticaudum, Phialophora cf. hyalina, and Morchella septimelata.

Authors:  Brenda D Wingfield; Gerald F Bills; Yang Dong; Wenli Huang; Wilma J Nel; Benedicta S Swalarsk-Parry; Niloofar Vaghefi; P Markus Wilken; Zhiqiang An; Z Wilhelm de Beer; Lieschen De Vos; Li Chen; Tuan A Duong; Yun Gao; Almuth Hammerbacher; Julie R Kikkert; Yan Li; Huiying Li; Kuan Li; Qiang Li; Xingzhong Liu; Xiao Ma; Kershney Naidoo; Sarah J Pethybridge; Jingzu Sun; Emma T Steenkamp; Magriet A van der Nest; Stephanie van Wyk; Michael J Wingfield; Chuan Xiong; Qun Yue; Xiaoling Zhang
Journal:  IMA Fungus       Date:  2018-06-11       Impact factor: 3.515

Review 10.  Antimicrobial Peptides: a New Frontier in Antifungal Therapy.

Authors:  Giuseppe Buda De Cesare; Shane A Cristy; Danielle A Garsin; Michael C Lorenz
Journal:  mBio       Date:  2020-11-03       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.